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Abstract
Background: Monitoring of cardiac output and blood pressure are standard procedures in critical
care medicine. Traditionally, invasive techniques like pulmonary artery catheter (PAC) and arterial
catheters are widely used. Invasiveness bears many risks of deleterious complications. Therefore,
a noninvasive reliable cardiac output (CO) and blood pressure monitoring system could improve
the safety of cardiac monitoring. The aim of the present study was to compare a noninvasive versus
a standard invasive cardiovascular monitoring system.
Methods: Nexfin HD is a continuous noninvasive blood pressure and cardiac output monitor
system and is based on the development of the pulsatile unloading of the finger arterial walls using
an inflatable finger cuff. During continuous BP measurement CO is calculated. We included 10
patients with standard invasive cardiac monitoring system (pulmonary artery catheter and arterial
catheter) comparing invasively obtained data to the data collected noninvasively using the Nexfin
HD.
Results:  Correlation between mean arterial pressure measured with the standard arterial
monitoring system and the Nexfin HD was r2 = 0.67 with a bias of -2 mmHg and two standard
deviations of ± 16 mmHg. Correlation between CO derived from PAC and the Nexfin HD was r2
= 0.83 with a bias of 0.23 l/min and two standard deviations of ± 2.1 l/min; the percentage error
was 29%.
Conclusion: Although the noninvasive CO measurement appears promising, the noninvasive
blood pressure assessment is clearly less reliable than the invasively measured blood pressure.
Therefore, according to the present data application of the Nexfin HD monitoring system in the
ICU cannot be recommended generally. Whether such a tool might be reliable in certain critically
ill patients remains to be determined.
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Background
Cardiovascular monitoring is a standard procedure in crit-
ical care medicine. Traditionally invasive techniques like
pulmonary artery catheter (PAC) and peripheral artery
catheters are widely used [1-3]. A further possibility of car-
diovascular monitoring is the PiCCO system[4]. These
techniques are well established and validated [5-7].
Besides the advantages of these invasive techniques for
clinical decision-making, these methods both bear the
risks of deleterious complications as e.g., bleeding, pneu-
mothorax and infection; PAC is also associated with the
risk of inducing pulmonary artery rupture [8,9]. Further-
more, these systems are cost intensive. Nexfin HD is a con-
tinuous noninvasive blood pressure (BP) and cardiac
output (CO) monitor (former called Modelflow, Fin-
apress) [10]. Its advantages are the noninvasive assess-
ment and its very easy application within minutes [11].
This device has been successfully used in healthy volun-
teers during orthostasis or for optimization of cardiac
resynchronization therapy[12,13]. To date, however, we
still lack data regarding the applicability of this system in
an intensive care unit (ICU) setting. The present study was
designed to evaluate the Nexfin HD device under clinical
conditions in a surgical ICU. Our hypothesis was that the
Nexfin device produces results comparable to a standard
invasive blood pressure monitoring system, i.e., PAC and
arterial line. The acceptance of a new method should be
judged against the ± 10-20% accuracy of the current refer-
ence method. Consequently, the limits of agreement
between the new and the reference technique of ± 30% is
considered acceptable [14].
Methods
Following approval by the local Ethics Committee which
waived the need for written informed consent for this ret-
rospective data analysis, patient data from a total of 10
patients treated on our intensive care unit in 2007 were
analyzed.
Nexfin HD technique
The method of the Nexfin HD (BMEYE B.V, Amsterdam,
Netherlands) is based on the development of the pulsatile
unloading of the finger arterial walls using an inflatable
finger cuff with a built-in photoelectric plethysmograph.
While continuously measuring BP the monitor calculates
CO. The method is described in detail by de Wilde and
colleagues [15]. The monitoring system is an approved
medical device in Switzerland.
Patients and data analysis
Data of ten critically ill patients in need of cardiovascular
monitoring with PAC (Edwards life sciences Germany
GMBH, Unterschleissheim, Germany) and invasive blood
pressure measurement (Drägger monitoring systems, Car-
bamed, Bern, Switzerland) in which the Nexfin HD was
additionally used during the stay in the ICU were col-
lected. Hourly Nexfin HD measurements obtained during
an 8 hour period were compared to arterial blood pressure
values and CO, respectively. A total of 80 data points for
blood pressure and CO were included.
Application of monitoring technique
Apart from PAC monitoring which was used in a stand-
ardized fashion [1-3], the Nexfin HD device was installed
by applying a compact and simple cuff on the middle fin-
ger according to the manufacturers' recommendations.
Signals derived from the cuff were analysed and presented
in real time on the Nexfin HD stand alone device.
Statistical analysis
The results between the 2 methods were analyzed statisti-
cally using correlation and linear regression analysis,
including calculation of bias and precision (Bland-Alt-
man analysis) [16] as well as calculation of the percentage
error according to Critchley and Critchley [14] (Statview
4.5, abacus concepts). Acceptance of a new technique
should rely on limits of agreement of up to ± 30% [14].
Data are presented as mean ± standard deviation.
Results
Baseline characteristics and clinical data
A total of ten critically ill patients monitored with PAC,
standard invasive arterial blood pressure monitoring and
Nexfin HD were included in this study. Arrhythmias were
not present during the recording periods. Four patients
were lung transplant recipients, 4 patients were liver trans-
plant recipients and 2 suffered from severe ARDS.
Mean age of the patients was 54 ± 12 years, average weight
was 74 ± 17 kg, average height was 168 ± 15 cm, average
mean arterial pressure (MAP) was 77 ± 13 mmHg, mean
heart rate was 98 ± 18 bpm; four of the 10 patients were
males.
All patients required norepinephrine as a vasoconstrictor
agent for hemodynamic stability. Mean norepinephrine
dose during data assessment was 12 ± 12 μg/min (range 2-
29 μg/min). Mean SAPS II score was 36 ± 17 and the ICU
mortality was 3/10 (30%).
Comparison of blood pressure measurement
Correlation, regression analysis and the Bland-Altman
analysis are shown in Figure 1. Correlation between MAP
determined invasively and MAP assessed by Nexfin was r2
= 0.67. Average MAP derived invasively was 80 ± 12
mmHg with a bias of -2 mmHg and 2 standard deviations
of ± 16 mmHg.BMC Anesthesiology 2009, 9:6 http://www.biomedcentral.com/1471-2253/9/6
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Comparison of cardiac output measurement
Correlation, regression analysis and the Bland-Altman
analysis are shown in Figure 2. Correlation between CO
derived by PAC and CO assessed by Nexfin was r2 = 0.83.
Mean CO determined by PAC was 7.2 ± 2.3 l/min with a
bias of 0.23 l/min, two standard deviations of ± 2.1 l/min
and the percentage error was 29%.
Discussion
The present study revealed that the noninvasive Nexfin
HD system cannot substitute standard invasive blood
pressure measurement while CO monitoring appears
more reliable in the presently investigated group of ten
critically ill patients.
The mean difference in MAP between the 2 methods was
2 ± 8 mmHg (2 SD were ± 16 mmHg and r2 = 0.67). This
is in contrast to the results reported by Schattenkerk et al,
who described a good correlation between the Nexfin HD
and blood pressure measurements determined by the
Riva-Rocchi/Korotkoff technique (RRK) [17]. Methodo-
logical differences preclude a direct comparison of their
patients with the presently investigated patients: Schat-
tenkerk et al., compared 2 non-invasive techniques based
on cuff measurement without including an invasive
method and did not investigate critically ill patients in
need of vasopressors.
A possible explanation for the observed difference
between the 2 systems might be diminished arterial per-
fusion in the fingers of our subjects. However, based on
the fact that for the same norepinephrine concentration
noninvasive blood pressure was higher compared to the
invasive blood pressure in approximately 50% of the
investigated patients it appears that the finger plethys-
mography was not to associated with impaired perfusion.
Clinical and therapeutic decision making is weakened by
the calculated standard deviation of ± 8 mmHg for the
MAP determined by the Nexfin HD device. I.e., for a MAP
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65 mmHg, the defined blood pressure target in septic
patients [18], we must expect a real MAP of 57 or 73
mmHg. Consequently, the MAP is either too low or too
high, thereby resulting in excessive or insufficient thera-
peutic interventions. This, in turn, might induce addi-
tional damage.
Therefore, our comparison of blood pressure measure-
ment indicates that the noninvasive technique cannot
properly replace an invasive system.
CO determined non-invasively using the Nexfin HD
device was within the recommended limits of agreement,
suggesting a fair to good accuracy. However, CO measure-
ment- although very interesting in critically ill patients -
does not have the same importance within the therapy of
critically ill patients as the MAP. Contrary to MAP CO is
not a target value within the early goal directed therapy
(EGDT) for septic patients [18]. Thus, although useful,
this finding alone does not justify its application in the
ICU as a substitute for an invasive monitoring system.
Given the small sample size the results must be inter-
preted very carefully. Interestingly, the original work of
Bland and Altman which describes the statistical method
used in this paper [16] was based on a sample size of 17
subjects with a total of 34 data points. Despite a smaller
sample size (10 patients) we included twice as many data
points (80 data points) in our analysis. Thus, our sample
size should allow us to reliably interpret the present
results.
Importantly, there were no clinical signs of disturbed
microcirculation of the fingers in these patients (dis-
colored and cold fingers) during application of the finger
cuff, indicating a safe use of the Nexfin HD system. The
noninvasiveness of this technique allows to avoid poten-
tial complications related to the invasive nature of the
other techniques.
Furthermore, this new finger plethysmography system is
very easy to use and quickly to install within minutes and
therefore could offer a quick and initial hemodynamic
overview, possibly providing important information on
trend of MAP and CO. This would allow to bridge the time
until a longer lasting invasive monitoring can be installed
in the case of a deteriorating patient.
Conclusion
Although CO measurement seems promising, noninva-
sive blood pressure assessed by the Nexfin HD device is
clearly less reliable than invasive blood pressure measure-
ment. Therefore, according to our data application of the
Nexfin HD monitoring system cannot generally be recom-
mended for the ICU. Whether such a tool is reliable in cer-
tain groups of critically ill patients has yet to be
determined.
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